RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis

por Chen, Dongdong, Schnepp, Robert W.
Publicado 2020

EMBR-12. TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA

por Shahab, Shubin, Schnepp, Robert, MacDonald, Tobey, Kenney, Anna
Publicado 2021

MEDB-63. Deciphering the role of LIN28B in Group 3 medulloblastoma

por Shahab, Shubin, Sun, Jessica, Schnepp, Robert, MacDonald, Tobey, Kenney, Anna
Publicado 2022

The LIN28B–let‐7–PBK pathway is essential for group 3 medulloblastoma tumor growth and survival

por Shahab, Shubin W., Roggeveen, Christianna M., Sun, Jiarong, Kunhiraman, Haritha, McSwain, Leon F., Juraschka, Kyle, Kumar, Sachin A., Saulnier, Olivier, Taylor, Michael D., Schniederjan, Matthew, Schnepp, Robert W., MacDonald, Tobey J, Kenney, Anna Marie
Publicado 2023

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase

por Chen, Dongdong, Cox, Julie, Annam, Jayabhargav, Weingart, Melanie, Essien, Grace, Rathi, Komal S., Rokita, Jo Lynne, Khurana, Priya, Cuya, Selma M., Bosse, Kristopher R., Pilgrim, Adeiye, Li, Daisy, Shields, Cara, Laur, Oskar, Maris, John M., Schnepp, Robert W.
Publicado 2020

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

por Diskin, Sharon J, Capasso, Mario, Schnepp, Robert W, Cole, Kristina A, Attiyeh, Edward F, Hou, Cuiping, Diamond, Maura, Carpenter, Erica L, Winter, Cynthia, Lee, Hanna, Jagannathan, Jayanti, Latorre, Valeria, Iolascon, Achille, Hakonarson, Hakon, Devoto, Marcella, Maris, John M
Publicado 2012

Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target

por Shields, Cara E., Potlapalli, Sindhu, Cuya‐Smith, Selma M., Chappell, Sarah K., Chen, Dongdong, Martinez, Daniel, Pogoriler, Jennifer, Rathi, Komal S., Patel, Shiv A., Oristian, Kristianne M., Linardic, Corinne M., Maris, John M., Haynes, Karmella A., Schnepp, Robert W.
Publicado 2021

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma

por Lee, Jasmine Y., Jonus, Hunter C., Sadanand, Arhanti, Branella, Gianna M., Maximov, Victor, Suttapitugsakul, Suttipong, Schniederjan, Matthew J., Shim, Jenny, Ho, Andrew, Parwani, Kiran K., Fedanov, Andrew, Pilgrim, Adeiye A., Silva, Jordan A., Schnepp, Robert W., Doering, Christopher B., Wu, Ronghu, Spencer, H. Trent, Goldsmith, Kelly C.
Publicado 2023